ChemoMetec - About the company
ChemoMetec is a public company based in Alleroed (Denmark), founded in 1997. It operates as an Automated cell counters and analyzers. ChemoMetec has raised an undisclosed amount in funding. The company has 38 active competitors, including 9 funded and 4 that have exited. Its top competitors include companies like LUMICKS, Xcell Biosciences and Biolog.
Company Details
ChemoMetec develops automated cell counters and analyzers, as well as associated consumables. Its flagship product range NucleoCounter has four different cytometers that use automated image analysis and fluorescent markers for cell counting, a sperm counter, a yeast cell counter, and two different somatic cell counters. Assays that can be performed on the cytometers include cell death and apoptosis assays, cell cycle assays, DNA fragmentation assays, transfection efficiency assays, mitochondrial potential assays, cell viability assays, vitality assays, mammalian and aggregated cell assays, whole blood assays, and the company's proprietary FlexiCyte assay for mammalian cell analysis.
- Website
- chemometec.com
- Email ID
- *****@chemometec.com
- Phone Number
- +45 **********
- Registered Address
- Sacramento, California
Key Metrics
Founded Year
1997
Location
Alleroed, Denmark
Stage
Public
Latest Funding Round
Investors
Ranked
8th among 38 active competitors
Employee Count
191 as on Aug 31, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with ChemoMetec
ChemoMetec is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Chemometec A/s CIN: 19828131 , Denmark, Active | - | - | ||
CHEMOMETEC INC CIN: 273548268 , United States, Active | Dec 26, 999 | - | 29 (As on Dec 31, 2024) | - |
ChemoMetec's IPO details
ChemoMetec got listed on Dec 22, 2006.
Click here to take a look at ChemoMetec's IPO in detail
Sign up to download ChemoMetec's company profile
ChemoMetec's funding and investors
ChemoMetec has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Oct 01, 2020 for $*****. 1 investor participated in its latest round. ChemoMetec has 1 institutional investor.
Here is the list of recent funding rounds of ChemoMetec:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 01, 2020 | 4615233 | Grant (prize money) | 2659924 | 8641608 | 2745852 | 5430385 |
View details of ChemoMetec's funding rounds and investors
ChemoMetec's founders and board of directors
Founder? Claim ProfileChemoMetec's employee count trend
ChemoMetec has 191 employees as of Aug 26. Here is ChemoMetec's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ChemoMetec's Competitors and alternates
Top competitors of ChemoMetec include LUMICKS, Xcell Biosciences and Biolog. Here is the list of Top 10 competitors of ChemoMetec, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | LUMICKS 2014, Amsterdam (Netherlands), Series D | Manufacturer of optical tweezers for single molecule analysis instruments | $93.4M | 63/100 | |
2nd | Xcell Biosciences 2012, San Francisco (United States), Series B | Developer of cell culture analysis device for cancer research | $40.9M | 59/100 | |
3rd | Biolog 1984, Hayward (United States), Series A | Provider of cell-based phenotyping technologies and assays | $33.6M | 58/100 | |
4th | IsoPlexis 2012, New Haven (United States), Acquired | Developer of multiplexed single-cell analysis tools for the diagnostics and life science research | $186M | 54/100 | |
5th | Axion Biosystems 2007, Atlanta (United States), Acquired | Develops multi-electrode array technology to provide access to cellular information analysis | $20.3M | 53/100 | |
6th | LevitasBio 2017, San Francisco (United States), Series C | Developer of single-cell imaging and profiling platform based on magnetic levitation technology | $73.8M | 49/100 | |
7th | Lucid Scientific 2012, Atlanta (United States), Series A | Developer of real-time cell analysers | $13.4M | 44/100 | |
8th | ChemoMetec 1997, Alleroed (Denmark), Public | Automated cell counters and analyzers | - | 43/100 | |
9th | ![]() Curiosis 2015, South Korea, Public | Developer of automation technologies for life science research laboratories | - | 42/100 | |
10th | CEIDOS 2019, Monthey (Switzerland), Funding Raised | Provider of cell culturing devices for patients cells modification | - | 32/100 |
Looking for more details on ChemoMetec's competitors? Click here to see the top ones
ChemoMetec's Investments and acquisitions
ChemoMetec has a total of 1 investment in Arctic Therapeutics. ChemoMetec has not made any acquisitions as of now.Reports related to ChemoMetec
Here is the latest report on ChemoMetec's sector:
News related to ChemoMetec
Media has covered ChemoMetec for a total of 14 events in the last 1 year, 3 of them have been about company updates and 2 about people movement.
•
•
ChemoMetec A/S upgrades revenue and operating profit guidance for FY26/27GlobeNewswire•Oct 05, 2026•ChemoMetec
•
•
ChemoMetec A/S: Shareholder announcement - BlackRock, Inc. increases its holding to 15.00%GlobeNewswire•Sep 16, 2026•BlackRock, ChemoMetec, Fagron
•
•
•
•
•
ChemoMetec Enters Letter of Intent With Roche DiagnosticsGlobeNewswire•Feb 04, 2026•ChemoMetec, Roche
•
Are you a Founder ?
FAQs about ChemoMetec
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
